What is the recommended management of septic shock, including fluid resuscitation, vasopressor therapy, antibiotics, and source control?

Management of Septic Shock

Septic shock is a medical emergency requiring immediate treatment with crystalloid fluid resuscitation (at least 30 mL/kg within 3 hours), early broad-spectrum antibiotics (within 1 hour), norepinephrine as first-line vasopressor targeting MAP ≥65 mmHg, and prompt source control. 1

Immediate Recognition and Initial Resuscitation

• Begin treatment immediately upon recognition—septic shock is a time-critical emergency. 1
• Administer at least 30 mL/kg of IV crystalloid fluid within the first 3 hours of recognizing sepsis-induced hypoperfusion. 1
• Use a dynamic fluid challenge technique: continue fluid administration only while hemodynamic parameters (cardiac output, pulse pressure variation, stroke volume variation, arterial pressure, heart rate) continue to improve, then stop when the response plateaus to avoid volume overload. 1, 2
• Target an initial mean arterial pressure of 65 mmHg in patients requiring vasopressors. 1
• Consider normalizing lactate levels as a marker of adequate tissue perfusion during resuscitation. 1

Fluid Selection

• Crystalloids are the first-line fluid choice for initial resuscitation and subsequent volume replacement. 1, 2
• Balanced crystalloids may be preferred over normal saline due to lower risk of renal dysfunction, though either is acceptable. 1, 2
• Add albumin to crystalloids only when patients require substantial amounts of crystalloid resuscitation—this is a weak recommendation based on low-quality evidence and should not be routine. 1, 2
• Never use hydroxyethyl starches for volume replacement in septic shock—strong evidence shows increased need for renal replacement therapy. 1, 2
• Avoid gelatin solutions; prefer crystalloids instead. 1, 2

Vasopressor Therapy

• Norepinephrine is the first-choice vasopressor and should be initiated early when fluid resuscitation alone does not achieve blood pressure goals. 1, 2
• Add vasopressin (up to 0.03 units/min) or epinephrine to norepinephrine when additional agents are needed to raise MAP to target or to decrease norepinephrine dosage. 1
• Use dopamine only in highly selected patients with low risk of tachyarrhythmias and absolute or relative bradycardia—it is not a first-line agent. 1
• Do not use low-dose vasopressin as the single initial vasopressor, and reserve doses higher than 0.03-0.04 units/min for salvage therapy when other agents fail. 1

Antimicrobial Therapy

• Obtain appropriate microbiologic cultures (including at least two sets of blood cultures—aerobic and anaerobic) before starting antimicrobials, but do not delay antibiotics if this causes substantial delay. 1
• Administer IV broad-spectrum antimicrobials within 1 hour of recognizing sepsis or septic shock, covering all likely pathogens including bacterial and potentially fungal or viral organisms. 1
• Narrow empiric antimicrobial therapy once pathogen identification and sensitivities are established or adequate clinical improvement is noted. 1
• Optimize antimicrobial dosing based on pharmacokinetic/pharmacodynamic principles and specific drug properties. 1

Source Control

• Promptly remove intravascular access devices that are possible sources of sepsis after establishing other vascular access. 1
• Identify and control the source of infection using the method that balances risks and benefits for the individual patient. 3

Hemodynamic Monitoring and Reassessment

• Reassess hemodynamic status frequently after initial fluid resuscitation to guide additional fluid administration. 1
• Perform further hemodynamic assessment (such as cardiac function evaluation) if clinical examination does not lead to a clear diagnosis of shock type. 1
• Use dynamic variables (pulse pressure variation, stroke volume variation) over static variables to predict fluid responsiveness when available. 1, 2

Common Pitfalls to Avoid

• Avoid excessive fluid resuscitation beyond hemodynamic improvement—the shift away from aggressive fluid strategies reflects recognition that volume overload worsens outcomes. 4
• Do not delay vasopressor initiation while pursuing aggressive fluid resuscitation—early vasopressor use (even peripherally) is increasingly recognized as safe and appropriate. 3, 4
• Do not use routine mixed venous oxygen saturation or central venous pressure monitoring—management has transitioned away from these targets. 4
• Avoid routine use of inotropes, excessive red blood cell transfusions, and supranormal oxygen delivery goals—these strategies have not shown benefit. 4, 5